Email Us
View Reports

USA Latanoprost Market Report 2017 Forecast to 2022 | Industry Analysis, Growth, Trends and Future Outlook

  • ID : 8937668  |  
  • Published : Dec-2017  |  
  • Region : North America  |  
  • Pages : 119   |  
  • Publisher : GIR (Global Info Research)

"Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness."_x000D_

_x000D_

_x000D_

Scope of the Report:_x000D_

This report focuses on the Latanoprost in United States market, to split the market based on manufacturers, states, type and application._x000D_

_x000D_

Market Segment by Manufacturers, this report covers_x000D_

Pfizer_x000D_

Mylan_x000D_

Novartis_x000D_

Apotex_x000D_

Teva_x000D_

Taj Pharma_x000D_

CR Zizhu_x000D_

_x000D_

Market Segment by States, covering_x000D_

California_x000D_

Texas_x000D_

New York_x000D_

Florida_x000D_

Illinois_x000D_

_x000D_

Market Segment by Type, covers_x000D_

Brand Drug_x000D_

Generic Drug_x000D_

_x000D_

Market Segment by Applications, can be divided into_x000D_

Open-angle Glaucoma_x000D_

Close-angle Glaucoma_x000D_

_x000D_

There are 17 Chapters to deeply display the United States Latanoprost market._x000D_

_x000D_

Chapter 1, to describe Latanoprost Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;_x000D_

_x000D_

Chapter 2, to analyze the manufacturers of Latanoprost, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;_x000D_

_x000D_

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;_x000D_

_x000D_

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Latanoprost, for each state, from 2012 to 2017;_x000D_

_x000D_

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;_x000D_

_x000D_

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;_x000D_

_x000D_

Chapter 12, Latanoprost market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;_x000D_

_x000D_

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc._x000D_

_x000D_

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);_x000D_

_x000D_

Chapter 15, to describe sales channel, distributors, traders, dealers etc._x000D_

_x000D_

Chapter 16 and 17, to describe Latanoprost Research Findings and Conclusion, Appendix, methodology and data source.

1 Market Overview_x000D_

1.1 Latanoprost Introduction_x000D_

1.2 Market Analysis by Type_x000D_

1.2.1 Brand Drug_x000D_

1.2.2 Generic Drug_x000D_

1.3 Market Analysis by Applications_x000D_

1.3.1 Open-angle Glaucoma_x000D_

1.3.2 Close-angle Glaucoma_x000D_

1.4 Market Analysis by States_x000D_

1.4.1 California Status and Prospect (2012-2022)_x000D_

1.4.2 Texas Status and Prospect (2012-2022)_x000D_

1.4.3 New York Status and Prospect (2012-2022)_x000D_

1.4.4 Florida Status and Prospect (2012-2022)_x000D_

1.4.5 Illinois Status and Prospect (2012-2022)_x000D_

1.5 Market Dynamics_x000D_

1.5.1 Market Opportunities_x000D_

1.5.2 Market Risk_x000D_

1.5.3 Market Driving Force_x000D_

2 Manufacturers Profiles_x000D_

2.1 Pfizer_x000D_

2.1.1 Profile_x000D_

2.1.2 Latanoprost Type and Applications_x000D_

2.1.2.1 Type 1_x000D_

2.1.2.2 Type 2_x000D_

2.1.3 Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

2.1.4 Business Overview_x000D_

2.1.5 Pfizer News_x000D_

2.2 Mylan_x000D_

2.2.1 Profile_x000D_

2.2.2 Latanoprost Type and Applications_x000D_

2.2.2.1 Type 1_x000D_

2.2.2.2 Type 2_x000D_

2.2.3 Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

2.2.4 Business Overview_x000D_

2.2.5 Mylan News_x000D_

2.3 Novartis_x000D_

2.3.1 Profile_x000D_

2.3.2 Latanoprost Type and Applications_x000D_

2.3.2.1 Type 1_x000D_

2.3.2.2 Type 2_x000D_

2.3.3 Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

2.3.4 Business Overview_x000D_

2.3.5 Novartis News_x000D_

2.4 Apotex_x000D_

2.4.1 Profile_x000D_

2.4.2 Latanoprost Type and Applications_x000D_

2.4.2.1 Type 1_x000D_

2.4.2.2 Type 2_x000D_

2.4.3 Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

2.4.4 Business Overview_x000D_

2.4.5 Apotex News_x000D_

2.5 Teva_x000D_

2.5.1 Profile_x000D_

2.5.2 Latanoprost Type and Applications_x000D_

2.5.2.1 Type 1_x000D_

2.5.2.2 Type 2_x000D_

2.5.3 Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

2.5.4 Business Overview_x000D_

2.5.5 Teva News_x000D_

2.6 Taj Pharma_x000D_

2.6.1 Profile_x000D_

2.6.2 Latanoprost Type and Applications_x000D_

2.6.2.1 Type 1_x000D_

2.6.2.2 Type 2_x000D_

2.6.3 Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

2.6.4 Business Overview_x000D_

2.6.5 Taj Pharma News_x000D_

2.7 CR Zizhu_x000D_

2.7.1 Profile_x000D_

2.7.2 Latanoprost Type and Applications_x000D_

2.7.2.1 Type 1_x000D_

2.7.2.2 Type 2_x000D_

2.7.3 CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

2.7.4 Business Overview_x000D_

2.7.5 CR Zizhu News_x000D_

3 United States Latanoprost Market Competition, by Manufacturer_x000D_

3.1 United States Latanoprost Sales and Market Share by Manufacturer (2016-2017)_x000D_

3.2 United States Latanoprost Revenue and Market Share by Manufacturer (2016-2017)_x000D_

3.3 United States Latanoprost Price by Manufacturers (2016-2017)_x000D_

3.4 Market Concentration Rate_x000D_

3.4.1 Top 3 Latanoprost Manufacturer Market Share_x000D_

3.4.2 Top 5 Latanoprost Manufacturer Market Share_x000D_

3.5 Market Competition Trend_x000D_

4 United States Latanoprost Market Analysis by States_x000D_

4.1 United States Latanoprost Sales Market Share by States_x000D_

4.2 United States Latanoprost Sales by States (2012-2017)_x000D_

4.3 United States Latanoprost Revenue (Value) by States (2012-2017)_x000D_

5 United States Market Segmentation Latanoprost by Type_x000D_

5.1 United States Latanoprost Sales, Revenue and Market Share by Type (2012-2017)_x000D_

5.1.1 United States Latanoprost Sales and Market Share by Type (2012-2017)_x000D_

5.1.2 United States Latanoprost Revenue and Market Share by Type (2012-2017)_x000D_

5.2 Brand Drug Sales Growth and Price_x000D_

5.2.1 United States Brand Drug Sales Growth (2012-2017)_x000D_

5.2.2 United States Brand Drug Price (2012-2017)_x000D_

5.3 Generic Drug Sales Growth and Price_x000D_

5.3.1 United States Generic Drug Sales Growth (2012-2017)_x000D_

5.3.2 United States Generic Drug Price (2012-2017)_x000D_

6 United States Market Segmentation Latanoprost by Application_x000D_

6.1 United States Latanoprost Sales Market Share by Application (2012-2017)_x000D_

6.2 Open-angle Glaucoma Sales Growth (2012-2017)_x000D_

6.3 Close-angle Glaucoma Sales Growth (2012-2017)_x000D_

7 California Latanoprost Sales, Revenue, by Type, Application and Manufacturers_x000D_

7.1 California Latanoprost Revenue, Sales and Growth Rate (2012-2017)_x000D_

7.2 California Latanoprost Sales and Market Share by Type_x000D_

7.3 California Latanoprost Sales by Application (2012-2017)_x000D_

8 New York Latanoprost Sales, Revenue, by Type, Application and Manufacturers_x000D_

8.1 New York Latanoprost Revenue, Sales and Growth Rate (2012-2017)_x000D_

8.2 New York Latanoprost Sales and Market Share by Type_x000D_

8.3 New York Latanoprost Sales by Application (2012-2017)_x000D_

9 Texas Latanoprost Sales, Revenue, by Type, Application and Manufacturers_x000D_

9.1 Texas Latanoprost Revenue, Sales and Growth Rate (2012-2017)_x000D_

9.2 Texas Latanoprost Sales and Market Share by Type_x000D_

9.3 Texas Latanoprost Sales by Application (2012-2017)_x000D_

10 Florida Latanoprost Sales, Revenue, by Type, Application and Manufacturers_x000D_

10.1 Florida Latanoprost Revenue, Sales and Growth Rate (2012-2017)_x000D_

10.2 Florida Latanoprost Sales and Market Share by Type_x000D_

10.3 Florida Latanoprost Sales by Application (2012-2017)_x000D_

11 Illinois Latanoprost Sales, Revenue, by Type, Application and Manufacturers_x000D_

11.1 Illinois Latanoprost Revenue, Sales and Growth Rate (2012-2017)_x000D_

11.2 Illinois Latanoprost Sales and Market Share by Type_x000D_

11.3 Illinois Latanoprost Sales by Application (2012-2017)_x000D_

12 Latanoprost Market Forecast (2017-2022)_x000D_

12.1 United States Latanoprost Sales, Revenue and Growth Rate (2017-2022)_x000D_

12.2 Latanoprost Market Forecast by States (2017-2022)_x000D_

12.3 Latanoprost Market Forecast by Type (2017-2022)_x000D_

12.4 Latanoprost Market Forecast by Application (2017-2022)_x000D_

13 Latanoprost Manufacturing Cost Analysis_x000D_

13.1 Latanoprost Key Raw Materials Analysis_x000D_

13.1.1 Key Raw Materials_x000D_

13.1.2 Price Trend of Key Raw Materials_x000D_

13.1.3 Key Suppliers of Raw Materials_x000D_

13.1.4 Market Concentration Rate of Raw Materials_x000D_

13.2 Proportion of Manufacturing Cost Structure_x000D_

13.2.1 Raw Materials_x000D_

13.2.2 Labor Cost_x000D_

13.2.3 Manufacturing Expenses_x000D_

13.3 Manufacturing Process Analysis of Latanoprost_x000D_

14 Industrial Chain, Sourcing Strategy and Downstream Buyers_x000D_

14.1 Latanoprost Industrial Chain Analysis_x000D_

14.2 Upstream Raw Materials Sourcing_x000D_

14.3 Raw Materials Sources of Latanoprost Major Manufacturers in 2016_x000D_

14.4 Downstream Buyers_x000D_

15 Sales Channel, Distributors, Traders and Dealers_x000D_

15.1 Sales Channel_x000D_

15.1.1 Direct Marketing_x000D_

15.1.2 Indirect Marketing_x000D_

15.1.3 Marketing Channel Future Trend_x000D_

15.2 Distributors, Traders and Dealers_x000D_

16 Research Findings and Conclusion_x000D_

17 Appendix_x000D_

17.1 Methodology_x000D_

17.2 Analyst Introduction_x000D_

17.3 Data Source

_x000D_

_x000D_

Figure Latanoprost Picture_x000D_

Table Product Specifications of Latanoprost_x000D_

Figure United States Sales Market Share of Latanoprost by Types in 2016_x000D_

Table Types of Latanoprost_x000D_

Figure Brand Drug Picture_x000D_

Table Major Manufacturers of Brand Drug_x000D_

Figure Generic Drug Picture_x000D_

Table Major Manufacturers of Generic Drug_x000D_

Table United States Latanoprost Sales Market Share by Applications in 2016_x000D_

Table Applications of Latanoprost_x000D_

Figure Open-angle Glaucoma Picture_x000D_

Figure Close-angle Glaucoma Picture_x000D_

Figure California Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)_x000D_

Figure Texas Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)_x000D_

Figure New York Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)_x000D_

Figure Florida Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)_x000D_

Figure Illinois Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)_x000D_

Table Pfizer Basic Information, Manufacturing Base and Competitors_x000D_

Table Pfizer Latanoprost Type and Applications_x000D_

Table Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

Table Mylan Basic Information, Manufacturing Base and Competitors_x000D_

Table Mylan Latanoprost Type and Applications_x000D_

Table Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

Table Novartis Basic Information, Manufacturing Base and Competitors_x000D_

Table Novartis Latanoprost Type and Applications_x000D_

Table Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

Table Apotex Basic Information, Manufacturing Base and Competitors_x000D_

Table Apotex Latanoprost Type and Applications_x000D_

Table Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

Table Teva Basic Information, Manufacturing Base and Competitors_x000D_

Table Teva Latanoprost Type and Applications_x000D_

Table Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

Table Taj Pharma Basic Information, Manufacturing Base and Competitors_x000D_

Table Taj Pharma Latanoprost Type and Applications_x000D_

Table Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

Table CR Zizhu Basic Information, Manufacturing Base and Competitors_x000D_

Table CR Zizhu Latanoprost Type and Applications_x000D_

Table CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_

Table United States Latanoprost Sales by Manufacturer (2016-2017)_x000D_

Figure United States Latanoprost Sales Market Share by Manufacturer in 2016_x000D_

Figure United States Latanoprost Sales Market Share by Manufacturer in 2017_x000D_

Table United States Latanoprost Revenue by Manufacturer (2016-2017)_x000D_

Figure United States Latanoprost Revenue Market Share by Manufacturer in 2015_x000D_

Figure United States Latanoprost Revenue Market Share by Manufacturer in 2016_x000D_

Table United States Latanoprost Price by Manufacturers (2016-2017)_x000D_

Figure Top 3 Latanoprost Manufacturer Market Share in 2016_x000D_

Figure Top 3 Latanoprost Manufacturer Market Share in 2017_x000D_

Figure Top 5 Latanoprost Manufacturer Market Share in 2016_x000D_

Figure Top 5 Latanoprost Manufacturer Market Share in 2017_x000D_

Figure United States Latanoprost Sales and Growth (2012-2017)_x000D_

Table United States Latanoprost Sales by States (2012-2017)_x000D_

Table United States Latanoprost Sales Market Share by States (2012-2017)_x000D_

Figure United States 2012 Latanoprost Sales Market Share by States_x000D_

Figure United States 2016 Latanoprost Sales Market Share by States_x000D_

Figure United States Latanoprost Revenue and Growth (2012-2017)_x000D_

Table United States Latanoprost Revenue by States (2012-2017)_x000D_

Table United States Latanoprost Revenue Market Share by States (2012-2017)_x000D_

Table United States 2012 Latanoprost Revenue Market Share by States_x000D_

Table United States 2016 Latanoprost Revenue Market Share by States_x000D_

Table United States Latanoprost Sales by Type (2012-2017)_x000D_

Table United States Latanoprost Sales Share by Type (2012-2017)_x000D_

Table United States Latanoprost Revenue by Type (2012-2017)_x000D_

Table United States Latanoprost Revenue Share by Type (2012-2017)_x000D_

Figure United States Brand Drug Sales Growth (2012-2017)_x000D_

Figure United States Brand Drug Price (2012-2017)_x000D_

Figure United States Generic Drug Sales Growth (2012-2017)_x000D_

Figure United States Generic Drug Price (2012-2017)_x000D_

Table United States Latanoprost Sales by Application (2012-2017)_x000D_

Table United States Latanoprost Sales Share by Application (2012-2017)_x000D_

Figure United States Open-angle Glaucoma Sales Growth (2012-2017)_x000D_

Figure United States Close-angle Glaucoma Sales Growth (2012-2017)_x000D_

Figure California Latanoprost Revenue and Growth (2012-2017)_x000D_

Figure California Latanoprost Sales and Growth (2012-2017)_x000D_

Table California Latanoprost Sales by Type (2012-2017)_x000D_

Table California Latanoprost Sales Market Share by Type (2012-2017)_x000D_

Table California Latanoprost Sales by Application (2012-2017)_x000D_

Table California Latanoprost Sales Market Share by Application (2012-2017)_x000D_

Figure New York Latanoprost Revenue and Growth (2012-2017)_x000D_

Figure New York Latanoprost Sales and Growth (2012-2017)_x000D_

Table New York Latanoprost Sales by Type (2012-2017)_x000D_

Table New York Latanoprost Sales Market Share by Type (2012-2017)_x000D_

Table New York Latanoprost Sales by Application (2012-2017)_x000D_

Table New York Latanoprost Sales Market Share by Application (2012-2017)_x000D_

Figure Texas Latanoprost Revenue and Growth (2012-2017)_x000D_

Figure Texas Latanoprost Sales and Growth (2012-2017)_x000D_

Table Texas Latanoprost Sales by Type (2012-2017)_x000D_

Table Texas Latanoprost Sales Market Share by Type (2012-2017)_x000D_

Table Texas Latanoprost Sales by Application (2012-2017)_x000D_

Table Texas Latanoprost Sales Market Share by Application (2012-2017)_x000D_

Figure Florida Latanoprost Revenue and Growth (2012-2017)_x000D_

Figure Florida Latanoprost Sales and Growth (2012-2017)_x000D_

Table Florida Latanoprost Sales by Type (2012-2017)_x000D_

Table Florida Latanoprost Sales Market Share by Type (2012-2017)_x000D_

Table Florida Latanoprost Sales by Application (2012-2017)_x000D_

Table Florida Latanoprost Sales Market Share by Application (2012-2017)_x000D_

Figure Illinois Latanoprost Revenue and Growth (2012-2017)_x000D_

Figure Illinois Latanoprost Sales and Growth (2012-2017)_x000D_

Table Illinois Latanoprost Sales by Type (2012-2017)_x000D_

Table Illinois Latanoprost Sales Market Share by Type (2012-2017)_x000D_

Table Illinois Latanoprost Sales by Application (2012-2017)_x000D_

Table Illinois Latanoprost Sales Market Share by Application (2012-2017)_x000D_

Figure United States Latanoprost Sales, Revenue and Growth Rate (2017-2022)_x000D_

Table United States Latanoprost Sales Forecast by States (2017-2022)_x000D_

Table United States Latanoprost Market Share Forecast by States (2017-2022)_x000D_

Table United States Latanoprost Sales Forecast by Type (2017-2022)_x000D_

Table United States Latanoprost Market Share Forecast by Type (2017-2022)_x000D_

Table United States Latanoprost Sales Forecast by Application (2017-2022)_x000D_

Table United States Latanoprost Market Share Forecast by Application (2017-2022)_x000D_

Table Sales Base and Market Concentration Rate of Raw Material_x000D_

Figure Price Trend of Key Raw Materials_x000D_

Table Key Suppliers of Raw Materials_x000D_

Figure Manufacturing Cost Structure of Latanoprost_x000D_

Figure Manufacturing Process Analysis of Latanoprost_x000D_

Figure Latanoprost Industrial Chain Analysis_x000D_

Table Raw Materials Sources of Latanoprost Major Manufacturers in 2016_x000D_

Table Major Buyers of Latanoprost_x000D_

Table Distributors/Traders/ Dealers List

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?